Searching for the immune basis of obsessive-compulsive disorder

NeuroImmunoModulation

Volumn 21, Issue 2-3, 2014, Pages 152-158

  Teixeira, Antonio Lucio ^a,b   Rodrigues, David Henrique ^a   Marques, Andrea Hovarth ^c   Miguel, Eurípedes C ^c   Fontenelle, Leonardo F ^d  

^a Faculdade de Medicina   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Anti basal ganglia antibodies; Obsessive compulsive disorder; Rheumatic chorea

Indexed keywords

4 AMINOBUTYRIC ACID; ANTISTREPTOLYSIN; AUTOANTIBODY; BASAL GANGLION ANTIBODY; BIOLOGICAL MARKER; CYTOKINE; GLUTAMIC ACID; GLYCINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUROTRANSMITTER; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TAURINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

ANXIETY DISORDER; ARTICLE; AUTOIMMUNE DISEASE; BASAL GANGLION; BIPOLAR DISORDER; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID; CHOREA MINOR; CLINICAL OBSERVATION; COGNITIVE THERAPY; CORPUS CALLOSUM; FUNCTIONAL NEUROIMAGING; GENERALIZED ANXIETY DISORDER; GENETIC ASSOCIATION; HERITABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; MAJOR DEPRESSION; NERVE STIMULATION; NEUROACANTHOCYTOSIS; NEUROSURGERY; NEUROTRANSMISSION; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PRIORITY JOURNAL; RHEUMATIC FEVER; SCHIZOPHRENIA; SEPARATION ANXIETY; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS INFECTION; TIC; TOXOPLASMA GONDII; TOXOPLASMOSIS; X CHROMOSOME; ANIMAL; IMMUNOLOGY; REVIEW;

ANIMALS; HUMANS; OBSESSIVE-COMPULSIVE DISORDER;

EID: 84907878444     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000356554     Document Type: Article

References (49)

1. Abramowitz JS, Taylor S, McKay D: Obsessive-compulsive disorder. Lancet 2009; 374: 491-499.
2. Murphy DL, Timpano KR, Wheaton MG, Greenberg BD, Miguel EC: Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues Clin Neurosci 2010; 12: 131-148.
3. Miguel EC, Leckman JF, Rauch S, Rosario-Campos MC, Hounie AG, Mercadante MT, Chacon P, Pauls DL: Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 2005; 10: 258-275.
4. Stein DJ, Fineberg NA, Bienvenu OJ, Denys D, Lochner C, Nestadt G, Leckman JF, Rauch SL, Phillips KA: Should OCD be classified as an anxiety disorder in DSM-V? Depress Anxiety 2010; 27: 495-506.
5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, American Psychiatric Association, 2013.
6. Rudin E: On the problem of compulsive disease with special reference to its hereditary relations (in undetermined language). Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr 1953; 191: 14-54.
7. Fontenelle LF, Hasler G: The analytical epidemiology of obsessive-compulsive disorder: risk factors and correlates. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1-15.
8. Taylor S: Molecular genetics of obsessivecompulsive disorder: a comprehensive metaanalysis of genetic association studies. Mol Psychiatry 2013; 18: 799-805.
9. Stewart SE, Yu D, Scharf JM, Neale BM, Fagerness JA, Mathews CA, et al: Genomewide association study of obsessive-compulsive disorder. Mol Psychiatry 2013; 18: 788-798.
10. Harrison BJ, Soriano-Mas C, Pujol J, Ortiz H, Lopez-Sola M, Hernandez-Ribas R, Deus J, Alonso P, Yucel M, Pantelis C, Menchon JM, Cardoner N: Altered corticostriatal functional connectivity in obsessive-compulsive disorder. Arch Gen Psychiatry 2009; 66: 1189-1200.
11. Greenberg BD, Rauch SL, Haber SN: Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology 2010; 35: 317-336.
12. Fontenelle LF, Harrison BJ, Yücel M, Pujol J, Fujiwara H, Pantelis C: Is there evidence of brain white-matter abnormalities in obsessive-compulsive disorder? A narrative review. Top Magn Reson Imaging 2009; 20: 291-298.
13. Walterfang M, Evans A, Looi JC, Jung HH, Danek A, Walker RH, Velakoulis D: The neuropsychiatry of neuroacanthocytosis syndromes. Neurosci Biobehav Rev 2011; 35: 1275-1283.
14. Swedo SE, Rapoport JL, Cheslow DL, Leonard HL, Ayoub EM, Hosier DM, Wald ER: High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry 1989; 146: 246-249.
15. Teixeira AL, Maia DP, Cardoso F: UFMG Sydenham's chorea rating scale (USCRS): reliability and consistency. Mov Disord 2005; 20: 585-591.
16. Alvarenga PG, Hounie AG, Mercadante MT, Diniz JB, Salem M, Spina G, Miguel EC: Obsessive-compulsive symptoms in heart disease patients with and without history of rheumatic fever. J Neuropsychiatry Clin Neurosci 2006; 18: 405-408.
17. Hounie AG, Pauls DL, Mercadante MT, Rosrio-Campos MC, Shavitt RG, de Mathis MA, de Alvarenga PG, Cri M, Miguel EC: Obsessive-compulsive spectrum disorders in rheumatic fever with and without Sydenham's chorea. J Clin Psychiatry 2004; 65: 994-999.
18. Alvarenga PG, Floresi AC, Torres AR, Hounie AG, Fossaluza V, Gentil AF, Pereira CA, Miguel EC: Higher prevalence of obsessivecompulsive spectrum disorders in rheumatic fever. Gen Hosp Psychiatry 2009; 31: 178-180.
19. Colony HS, Malamud N: Sydenham's chorea: a clinicopathologic study. Neurology 1956; 6: 672-676.
20. Giedd JN, Rapoport JL, Kruesi MJ, Parker C, Schapiro MB, Allen AJ, Leonard HL, Kaysen D, Dickstein DP, Marsh WL, et al: Sydenham's chorea: magnetic resonance imaging of the basal ganglia. Neurology 1995; 45: 2199-2202.
21. Rose NR, Bona C: Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993; 14: 426-430.
22. Brimberg L, Benhar I, Mascaro-Blanco A, Alvarez K, Lotan D, Winter C, Klein J, Moses AE, Somnier FE, Leckman JF, Swedo SE, Cunningham MW, Joel D: Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 2012; 37: 2076-2087.
23. Teixeira AL, Guimares MM, Romano-Silva MA, Cardoso F: Serum from Sydenham's chorea patients modifies intracellular calcium levels in PC12 cells by a complement-independent mechanism. Mov Disord 2005; 20: 843-845.
24. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW: Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003; 9: 914-920.
25. Kirvan CA, Cox CJ, Swedo SE, Cunningham MW: Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J Immunol 2007; 178: 7412-7421.
26. Hounie AG, Pauls DL, do Rosario-Campos MC, Mercadante MT, Diniz JB, De Mathis MA, De Mathis ME, Chacon P, Shavitt RG, Curi M, Guilherme L, Miguel EC: Obsessivecompulsive spectrum disorders and rheumatic fever: a family study. Biol Psychiatry 2007; 61: 266-272.
27. Seixas AA, Hounie AG, Fossaluza V, Curi M, Alvarenga PG, De Mathis MA, De Mathis ME, Vallada H, Pauls D, de Bragana Pereira CA, Miguel EC: Anxiety disorders and rheumatic fever: is there an association? CNS Spectr 2008; 13: 1039-1046.
28. Ramasawmy R, Fa KC, Spina G, Victora GD, Tanaka AC, Palcios SA, Hounie AG, Miguel EC, Oshiro SE, Goldberg AC, Kalil J, Guilherme L: Association of polymorphisms within the promoter region of the tumor necrosis factor-α with clinical outcomes of rheumatic fever. Mol Immunol 2007; 44: 1873-1878.
29. Hounie AG, Cappi C, Cordeiro Q, Sampaio AS, Moraes I, Rosrio MC, Palcios SA, Goldberg AC, Vallada HP, Machado-Lima A, Nakano E, Kalil J, Pauls D, Pereira CA, Guilherme L, Miguel EC: TNF-α polymorphisms are associated with obsessive-compulsive disorder. Neurosci Lett 2008; 442: 86- 90.
30. Kurlan R, Johnson D, Kaplan EL, Tourette Syndrome Study Group: Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics 2008; 121: 1188-1197.
31. Dale RC: Immune-mediated extrapyramidal movement disorders, including Sydenham chorea. Handb Clin Neurol 2013; 112: 1235-1241.
32. Rocha FF, Correa H, Teixeira AL: Obsessivecompulsive disorder and immunology: a review. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1139-1146.
33. Maina G, Albert U, Bogetto F, Borghese C, Berro AC, Mutani R, Rossi F, Vigliani MC: Anti-brain antibodies in adult patients with obsessive-compulsive disorder. J Affect Disord 2009; 116: 192-200.
34. Nicholson TR, Ferdinando S, Krishnaiah RB, Anhoury S, Lennox BR, Mataix-Cols D, Cleare A, Veale DM, Drummond LM, Fineberg NA, Church AJ, Giovannoni G, Heyman I: Prevalence of anti-basal ganglia antibodies in adult obsessive-compulsive disorder: cross-sectional study. Br J Psychiatry 2012; 200: 381-386.
35. Bhattacharyya S, Khanna S, Chakrabarty K, Mahadevan A, Christopher R, Shankar SK: Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. Neuropsychopharmacology 2009; 34: 2489-2496.
36. Fabiani S, Pinto B, Bruschi F: Toxoplasmosis and neuropsychiatric diseases: can serological studies establish a clear relationship? Neurol Sci 2013; 34: 417-425.
37. Miman O, Mutlu EA, Ozcan O, Atambay M, Karlidag R, Unal S: Is there any role of Toxoplasma gondii in the etiology of obsessivecompulsive disorder? Psychiatry Res 2010; 177: 263-265.
38. Dietrich DE, Zhang Y, Bode L, Münte TF, Hauser U, Schmorl P, Richter-Witte C, Gdecke-Koch T, Feutl S, Schramm J, Ludwig H, Johannes S, Emrich HM: Brain potential amplitude varies as a function of Borna disease virus-specific immune complexes in obsessive-compulsive disorder. Mol Psychiatry 2005; 10: 519-520.
39. Rotge JY, Aouizerate B, Tignol J, Bioulac B, Burbaud P, Guehl D: The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder: an integrative approach from genes to symptoms. Neuroscience 2010; 165: 408-417.
40. Gray SM, Bloch MH: Systematic review of proinflammatory cytokines in obsessivecompulsive disorder. Curr Psychiatry Rep 2012; 14: 220-228.
41. Mason JL, Suzuki K, Chaplin DD, Matsushima GK: Interleukin-1β promotes repair of the CNS. J Neurosci 2001; 21: 7046-7052.
42. Lopez KC, Lalonde F, Mattai A, Wade B, Clasen L, Rapoport J, Giedd JN: Quantitative morphology of the corpus callosum in obsessive-compulsive disorder. Psychiatry Res 2013; 212: 1-6.
43. Fontenelle LF, Barbosa IG, Luna JV, de Sousa LP, Abreu MN, Teixeira AL: A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry 2012; 53: 797-804.
44. Scalzo P, Kummer A, Cardoso F, Teixeira AL: Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease. J Neuroimmunol 2009; 216: 122-125.
45. Murphy ML, Pichichero ME: Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 2002; 156: 356-361.
46. Mittleman BB, Castellanos FX, Jacobsen LK, Rapoport JL, Swedo SE, Shearer GM: Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J Immunol 1997; 159: 2994-2999.
47. Carpenter LL, Heninger GR, McDougle CJ, Tyrka AR, Epperson CN, Price LH: Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania. Psychiatry Res 2002; 112: 257-262.
48. Marazziti D, Mungai F, Masala I, Baroni S, Vivarelli L, Ambrogi F, Catena Dell'Osso M, Consoli G, Massimetti G, Dell'Osso L: Normalisation of immune cell imbalance after pharmacological treatments of patients suffering from obsessive-compulsive disorder. J Psychopharmacol 2009; 23: 567-573.
49. Marazziti D, Presta S, Pfanner C, Gemignani A, Rossi A, Sbrana S, Rocchi V, Ambrogi F, Cassano GB: Immunological alterations in adult obsessive-compulsive disorder. Biol Psychiatry 1999; 46: 810-814.